More than 150 former employees of the US Environmental Protection Agency (EPA) have appealed to lawmakers in the state of Virginia not to approve new Republican governor Glenn Youngkin’s nomination of former EPA administrator Andrew Wheeler as the state’s Secretary of Natural Resources.
In a decision that could sound a cautionary note for other countries hoping to boost Covid-19 vaccination numbers this way, a US appellate court has put a temporary hold on US president Joe Biden’s plan to introduce a vaccine mandate through an executive order called the Emergency Temporary Standard on Vaccination and Testing (ETS).
As the end of Donald Trump’s term as US president nears, environmental groups and even some career staffers within the Environmental Protection Agency (EPA) are scrambling to thwart last-minute efforts by the outgoing administration to cast in stone its rollback of Obama-era antipollution and safety legislation.
Alex Azar, US Secretary of Health and Human Services (HHS), is rumored to be plotting for the Trump administration to oust FDA Commissioner Stephen Hahn in retaliation for the health agency’s issuing its own guidance for approving a Covd-19 vaccine independently of the White House.
NGO Public Citizen has filed a lawsuit against the US Department of Health and Human Services (HHS), seeking to force disclosure of the terms of contracts worth billions of dollar that have been awarded to drugmakers for Covid-19 vaccine development and manufacturing.
The administration of US president Donald Trump said on Oct. 6 it planned to override the tightening of safety precautions for Covid-19 vaccine proposed by the Food and Drug Administration (FDA) two weeks ago, over fears these could delay approval. Later in the day, it did an unexplained about-turn after the FDA published the guidelines on its own website as part of a briefing for outside vaccine advisers.
US president Donald Trump has said he believes the White House could override the US Food and Drug Administration (FDA) if the national health watchdog goes ahead with mooted plans to toughen standards for approval of a Covid-19 vaccine or an Emergency Use Authorization.
After a roller coaster ride entailing months of on again-off again negotiations with US president Donald Trump over drug prices, the country’s pharmaceutical industry is licking its wounds and gearing up for a fight.
As the US death toll from Covid-19 creeps past the 170,000 mark, with a proven vaccine still months away, US president Donald Trump has begun promoting yet another miracle cure for the novel coronavirus. In this case, the focus is on oleandrin, an extract from the oleander plant.
The administration of US president Donald Trump canceled a planned meeting with pharmaceutical industry representatives in Washington on Jul. 28 after none said they planned to attend. The meeting had been called to discuss drug prices after the president announced four executive orders on Jul. 24.
